SCHEMBL29396186

SCHEMBL29396186

CON(C)C(=O)c1c[nH]c2ncccc12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K1 Q02750 1/20 0.68
CNR2 P34972 1/20 0.46
CAMKK2 Q96RR4 2/20 0.46
ADORA2A P29274 1/20 0.44
MTNR1A P48039 1/20 0.44
KMT2A Q03164 1/20 0.43
AXL P30530 2/20 0.43
CCNE1 P24864 3/20 0.42
CDK2 P24941 3/20 0.42
DYRK1A Q13627 2/20 0.42
BRAF P15056 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
NEK2 P51955 1/20 0.42
HTR2C P28335 1/20 0.42
GPR84 Q9NQS5 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
KIF20A O95235 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12500787 1.00 MAP2K1 (0.68) MAP2K1CNR2CAMKK2ADORA2AMTNR1A
SCHEMBL16472206 0.85 MAP2K1 (0.66) MAP2K1CNR2CAMKK2ADORA2AMTNR1A
SCHEMBL29526844 0.81 MAP2K1 (1.00) MAP2K1CNR2CAMKK2ADORA2AMTNR1A
SCHEMBL1607007 0.81 MAP2K1 (1.00) MAP2K1CNR2CAMKK2ADORA2AMTNR1A
Methoxymethane SCHEMBL28146835 0.81 MAP2K1 (0.77) MAP2K1CNR2CAMKK2ADORA2AMTNR1A
SCHEMBL1940550 0.78 MAP2K1 (0.73) MAP2K1CNR2CAMKK2ADORA2AMTNR1A
SCHEMBL30368631 0.78 MAP2K1 (0.64) MAP2K1CNR2CAMKK2ADORA2AMTNR1A
SCHEMBL22558960 0.78 MAP2K1 (0.43) MAP2K1KMT2ACYP2C19HTR2C
SCHEMBL2991525 0.77 MAP2K1 (0.71) MAP2K1CNR2CAMKK2ADORA2AMTNR1A
SCHEMBL985214 0.77 MAP2K1 (0.71) MAP2K1CNR2CAMKK2ADORA2AMTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3956327-A1 CHIRAL INDOLE COMPOUNDS AND THEIR USE Ariagen, Inc. (US) 2022-02-23 EP disclosed